Anbio Biotechnology Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 29, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Cap	509	1,320	-	-	-	-
Market Cap Growth	-77.20%	-	-	-	-	-
Enterprise Value	496.8	1,308	0	0	0	0
Last Close Price	11.59	30.07	-	-	-	-
PE Ratio	79.04	204.56	-	-	-	-
PS Ratio	58.83	152.64	-	-	-	-
PB Ratio	16.87	43.77	-	-	-	-
P/TBV Ratio	16.79	43.55	-	-	-	-
EV/Sales Ratio	57.45	151.26	-	-	-	-
EV/EBITDA Ratio	86.13	226.76	-	-	-	-
EV/EBIT Ratio	86.13	226.76	-	-	-	-
Net Debt / Equity Ratio	-0.39	-0.39	-0.68	-0.65	-0.69	-1.65
Net Debt / EBITDA Ratio	-2.06	-2.06	-5.89	-4.91	-	-1.70
Net Debt / FCF Ratio	1.77	1.77	-5.65	-10.78	-	-1.00
Asset Turnover	0.35	0.35	0.47	0.45	0	0.90
Inventory Turnover	-	-	-	18.94	0	-
Quick Ratio	177.12	177.12	7.41	11.65	6.14	2.06
Current Ratio	344.31	344.31	10.71	15.86	9.88	2.07
Return on Equity (ROE)	27.05%	27.05%	14.83%	16.47%	0.00%	100.00%
Return on Assets (ROA)	23.46%	23.46%	11.49%	13.17%	0.00%	49.96%
Return on Invested Capital (ROIC)	48.70%	48.70%	37.79%	43.53%	0.00%	-
Return on Capital Employed (ROCE)	24.36%	24.36%	12.47%	14.33%	0.00%	96.85%
Earnings Yield	1.26%	0.49%	-	-	-	-
Buyback Yield / Dilution	-3.26%	-3.27%	-97.30%	-21435215.00%	0.00%	-
Total Shareholder Return	-3.26%	-3.27%	-97.30%	-21435215.00%	0.00%	-

SEC Filings: 10-K · 10-Q